Drug Shortage Report for ROPIVACAINE HYDROCHLORIDE INJECTION, USP

Last updated on 2018-10-02 History
Report ID 51677
Drug Identification Number 02439379
Brand name ROPIVACAINE HYDROCHLORIDE INJECTION, USP
Common or Proper name ROPIVACAINE HYDROCHLORIDE INJECTION, USP
Company Name FRESENIUS KABI CANADA LTD
Active Ingredient(s) ROPIVACAINE HYDROCHLORIDE
Strength(s) 2mg/mL
Dosage form(s) Solution
Route of administration Epidural, Infiltration
Packaging size 100 mL bag
ATC code N01BB
ATC description Anesthetics. Local
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2018-06-01
Estimated end date
Actual end date 2018-10-01
Shortage status Resolved
Updated date 2018-10-02
Company comments This product will be available through all MDP and McKesson locations effective Monday October 1, 2018.
Health Canada comments
Contact Address 165 GALAXY BLVD, SUITE 100
TORONTO, ONTARIO
CANADA M9W 0C8
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v9 2018-10-02 English Compare
v8 2018-09-25 French Compare
v7 2018-09-25 English Compare
v6 2018-09-25 English Compare
v5 2018-09-25 English Compare
v4 2018-08-30 French Compare
v3 2018-08-30 English Compare
v2 2018-06-06 French Compare
v1 2018-06-06 English Compare